Cargando…

Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001–2017

The International Classification of Diseases (10(th) Version) categorizes major depressive disorder (MDD) according to severity. Guidelines provide recommendations for the treatment of MDD according to severity. Aim of this study was to assess real-life utilization of psychotropic drugs based on sev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seifert, Johanna, Maier, Hannah B., Führmann, Fabienne, Bleich, Stefan, Stübner, Susanne, Sieberer, Marcel, Bernegger, Xueqiong, Greil, Waldemar, Schüle, Cornelius, Toto, Sermin, Grohmann, Renate, Reinhard, Matthias A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2022
Materias:	Psychiatry and Preclinical Psychiatric Studies - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217868/ https://www.ncbi.nlm.nih.gov/pubmed/35524828 http://dx.doi.org/10.1007/s00702-022-02504-6

Ejemplares similares

Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017
por: Seifert, Johanna, et al.
Publicado: (2021)

Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016
por: Glocker, Catherine, et al.
Publicado: (2023)

Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015
por: Glocker, C., et al.
Publicado: (2021)

Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study
por: Toto, Sermin, et al.
Publicado: (2019)

Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project
por: Stübner, Susanne, et al.
Publicado: (2018)

Psychotropic drug-induced hyponatremia: results from a drug surveillance program–an update
por: Seifert, Johanna, et al.
Publicado: (2021)

Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program
por: Friedrich, Michaela-Elena, et al.
Publicado: (2015)

Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP
por: Haeberle, Anne, et al.
Publicado: (2012)

Cardiovascular Adverse Reactions During Antipsychotic Treatment: Results of AMSP, A Drug Surveillance Program Between 1993 and 2013
por: Friedrich, Michaela-Elena, et al.
Publicado: (2019)

Electroconvulsive therapy and adiposity-related parameters in treatment-resistant depressed patients
por: Maier, Hannah Benedictine, et al.
Publicado: (2022)

Pharmacotherapy of 1,044 inpatients with posttraumatic stress disorder: current status and trends in German-speaking countries
por: Reinhard, Matthias A., et al.
Publicado: (2020)

COVID-19-Impfung unter Psychopharmakotherapie
por: Seifert, Johanna, et al.
Publicado: (2021)

Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data
por: de Bardeci, Mateo, et al.
Publicado: (2022)

Cardiovascular Adverse Reactions During Antidepressant Treatment: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2010
por: Spindelegger, Christoph Josef, et al.
Publicado: (2015)

Epinephrine levels decrease in responders after electroconvulsive therapy
por: Pollak, Christoph, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics
por: Moschny, Nicole, et al.
Publicado: (2021)

Neurological soft signs are increased in major depressive disorder irrespective of treatment
por: Schülke, Rasmus, et al.
Publicado: (2023)

Antimicrobial stewardship programme (AMSP) practices in India
por: Walia, Kamini, et al.
Publicado: (2015)

Long-term changes in serum levels of lipoproteins in children and adolescents with attention-deficit/hyperactivity disorder (ADHD)
por: Huber, Franziska, et al.
Publicado: (2023)

Clinical and sociodemographic predictors of inpatient admission after presentation in a psychiatric emergency room: an observational study
por: Gisy, Gianna L., et al.
Publicado: (2023)

Impact of the COVID-19 lockdown on screen media use in patients referred for ADHD to child and adolescent psychiatry: an introduction to problematic use of the internet in ADHD and results of a survey
por: Werling, Anna Maria, et al.
Publicado: (2021)

Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional study
por: Schulze Westhoff, Martin, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on mental health and family situation of clinically referred children and adolescents in Switzerland: results of a survey among mental health care professionals after 1 year of COVID-19
por: Werling, Anna Maria, et al.
Publicado: (2022)

Psychiatric Symptoms in Patients with Shiga Toxin-Producing E. coli O104:H4 Induced Haemolytic-Uraemic Syndrome
por: Kleimann, Alexandra, et al.
Publicado: (2014)

Autoantibody-associated psychiatric syndromes in children: link to adult psychiatry
por: Hansen, Niels, et al.
Publicado: (2021)

Controversies regarding lithium-associated weight gain: case–control study of real-world drug safety data
por: Greil, Waldemar, et al.
Publicado: (2023)

A case series of serious and unexpected adverse drug reactions under treatment with cariprazine
por: Heck, Johannes, et al.
Publicado: (2021)

Psychopharmakotherapie in Zeiten der COVID-19-Pandemie
por: Seifert, J., et al.
Publicado: (2020)

Peripandemic psychiatric emergencies: impact of the COVID-19 pandemic on patients according to diagnostic subgroup
por: Seifert, Johanna, et al.
Publicado: (2021)

Antidepressants: From MAOIs to SSRIs and more
por: Ramachandraih, Chaitra T., et al.
Publicado: (2011)

Diabetes mellitus type II as a risk factor for depression: a lower than expected risk in a general practice setting
por: Aarts, S., et al.
Publicado: (2009)

Old but still gold: Lithium in stabilizing the mood
por: Balon, Richard
Publicado: (2009)

Arvid Carlsson, and the story of dopamine
por: Yeragani, Vikram K., et al.
Publicado: (2010)

Paul Eugen Bleuler and the origin of the term schizophrenia (SCHIZOPRENIEGRUPPE)
por: Ashok, Ahbishekh Hulegar, et al.
Publicado: (2012)

Penfield – A great explorer of psyche-soma-neuroscience
por: Kumar, Rahul, et al.
Publicado: (2011)

Emil Kraepelin: A pioneer of scientific understanding of psychiatry and psychopharmacology
por: Ebert, Andreas, et al.
Publicado: (2010)

Does cultural integration explain a mental health advantage for adolescents?
por: Bhui, Kamaldeep S, et al.
Publicado: (2012)

Emergency Department Patients with Psychiatric Complaints Return at Higher Rates than Controls
por: Madsen, Troy E., et al.
Publicado: (2009)

The Clinical Differentiation of Cerebellar Infarction from Common Vertigo Syndromes
por: Nelson, James A., et al.
Publicado: (2009)

The story of antipsychotics: Past and present
por: Ramachandraiah, Chaitra T., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2jj4d3dnv4vqk4gsn60g295011